# Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study

> **NCT05301335** · NA · COMPLETED · sponsor: **SpineX Inc.** · enrollment: 126 (actual)

## Conditions studied

- Neurogenic Bladder
- Spinal Cord Injuries (Complete and Incomplete)
- Stroke
- Multiple Sclerosis

## Interventions

- **DEVICE:** SCONE

## Key facts

- **NCT ID:** NCT05301335
- **Lead sponsor:** SpineX Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-25
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 126 (ACTUAL)
- **Last updated:** 2025-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05301335

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05301335, "Spinal COrd NeuromodulaTor by SpIneX and ScoNE to Treat NeurogeniC BladdEr - SCONE "CONTINENCE" Clinical Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05301335. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*